Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 186
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation...
Incannex to Present at the H.C. Wainwright First Annual Mental Health...
Psychedelic Bulletin #108 – COMPASS Survives Patent Challenges; MindMed Secures Candyflipping...
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st...
Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration...
Yale’s Department of Psychiatry Chair to Join Clearmind Medicine
Diamond Therapeutics Achieves Last Patient Last Visit in Clinical Trial of...
Gilgamesh Announces Clinical Candidates For Two Programs With First In Human...
Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites...
Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel...
Load more